Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Frontage Laboratories unveiled its newest Contract Research, Development and Manufacturing Organization (CRDMO) facility during a grand open house event held on May 22, 2025, at its campus in Exton, Pennsylvania.
read more
Frontida BioPharm announced the FDA issued a closure letter for its Philadelphia manufacturing site.
read more
Frontier Scientific Solutions announced the appointment of Michelle D’Angelo as Chief Commercial Officer (CCO).
read more
Tuesday, February 11, 2025
Frontier Scientific Solutions announced that construction of its state-of-the-art cGMP temperature-controlled facilities at Wilmington International Airport (ILM) is in full swing with the first vertical structures being installed. This ...
read more
Wednesday, December 19, 2018
Alvotech announced Japan-based Fuji Pharma has acquired a 4.2% stake in the business for approximately $50 million.
read more
Fujifilm has announced the extension of its gene therapy and viral vaccine Fill/Finish capabilities to provide services in support of late phase candidates and commercial supply.
read more
FUJIFILM Holdings America Corporation announced additional leadership responsibilities for three key leaders in its Life Sciences Group companies.
read more
FUJIFILM Biotechnologies has launched ShunzymeX precision purification technology, which simplifies downstream processing for complex biologics
read more
Friday, September 05, 2025
FUJIFILM Biotechnologies announced the appointment of Samuel Hernandez, Ph.D., as senior vice president and site head for its College Station, Texas facility. With over two decades of biotechnology and pharmaceutical leadership experience, Dr. ...
read more
Wednesday, April 15, 2026
FUJIFILM Biotechnologies announced the opening of its new, 2,000 square meter (m2) quality control (QC) laboratory at its Hillerød, Denmark, commercial scale manufacturing site.
read more
Thursday, August 01, 2019
FUJIFILM has completed the acquisition of Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark from Biogen.
read more
FUJIFILM Diosynth Biotechnologies has announced an expansion to its United Kingdom location through the creation of a new BioCampus.
read more
FUJIFILM Diosynth Biotechnologies has commenced the planned capacity expansion of its Flexible Biomanufacturing Facility at its College Station, Texas location.
read more
FUJIFILM Diosynth Biotechnologies U.S.A., Inc., a Biologics Contract Development and Manufacturing Organization with experience focused on the development and manufacture of recombinant biopharmaceuticals including proteins, vaccines, and monoclonal ...
read more
Wednesday, August 27, 2014
FUJIFILM Diosynth Biotechnologies has announced continued expansion of its cell culture manufacturing capabilities with the addition of two 2000L single-use bioreactors. One each of these is being installed at the company's sites in Research Triangle...
read more